Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Haloperidol and Yohimbine

supplement:

Yohimbine

Research Papers that Mention the Interaction

Moreover, in rats treated with haloperidol for 10 days, the effect of yohimbine on striatal homovanillic acid and acetylcholine levels was markedly reduced.
Yohimbine failed to further enhance striatal homovanillic acid levels in animals pretreated with a supramaximal dose of haloperidol.
The Journal of pharmacology and experimental therapeutics  •  1980  |  View Paper
Yohimbine diminished the activity of the extract in the acetic acid test meanwhile haloperidol enhanced its effect.
Journal of ethnopharmacology  •  2012  |  View Paper
Administration of either the alpha-2 adrenoreceptor antagonist yohimbine (0.1 to 1.0 mg/kg) or the dopamine receptor antagonist haloperidol (1 to 5 mg/kg) caused a partial reversal ofl-dopa-induced protection but not the protective actions of subcutaneous cholecystokinin (100 μg/kg).
Journal of Gastrointestinal Surgery  •  2007  |  View Paper
Antagonism studies were conducted using the selective 5-HT1A receptor antagonist …-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexanecarboxamide dihydrochloride (WAY100635).ResultsIdazoxan, efaroxan, and yohimbine significantly … haloperidol (2.5 mg/kg, SC) in the CLP test and the actions … significantly blocked by pre-treatment with WAY100635 (0.63 mg/kg, SC).
Psychopharmacology  •  2004  |  View Paper
Prior treatment with haloperidol (1 mg/kg), D1/D2 receptor antagonist haloperidol, sulpiride (50 mg/kg), a selective D2 receptor antagonist, yohimbine (5 mg/kg), a alpha2-adrenoreceptor antagonist but not by SCH 23390 a, selective D1 receptor antagonist blocked this response.
Indian journal of experimental biology  •  2003  |  View Paper
The M1 antagonist scopolamine and α2 antagonist yohimbine were able to reduce the catalepsy induced by HP and HP+Δ9‐THC in a similar manner.
British journal of pharmacology  •  2003  |  View Paper
Injection of haloperidol simultaneous to an effective dose of yohimbine , blocked the ability of the latter to reverse sexual satiation.
European journal of pharmacology  •  1999  |  View Paper
Pretreatment with high dose of yohimbine (0.5 mg/kg), haloperidol , cyproheptadine, atropine and a combination of atropine and yohimbine significantly reversed the activity.
Indian journal of experimental biology  •  1993  |  View Paper
Yohimbine (2.5 mg/kg) also enhanced memory retrieval, as shown by haloperidol.
Methods and findings in experimental and clinical pharmacology  •  1991  |  View Paper
The dose-dependent diuretic effect of 1 or 10 mg/kg haloperidol was significant from 4 hr afterward, and the haloperidol-induced diuresis was prevented by pretreatment with phenoxybenzamine, prazosin or yohimbine.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica  •  1986  |  View Paper
Show More